rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1994-5-12
|
pubmed:abstractText |
Tumor tyrosine kinase activity associated with the epidermal growth factor receptor (EGFR) and localization of anti-EGFR monoclonal antibody RG 83852 were studied in patients with non-small-cell lung cancer (NSCLC) and head and neck cancer.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
730-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8151316-Antibodies, Monoclonal,
pubmed-meshheading:8151316-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:8151316-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:8151316-Head and Neck Neoplasms,
pubmed-meshheading:8151316-Humans,
pubmed-meshheading:8151316-Immunohistochemistry,
pubmed-meshheading:8151316-Infusions, Intravenous,
pubmed-meshheading:8151316-Lung Neoplasms,
pubmed-meshheading:8151316-Protein-Tyrosine Kinases,
pubmed-meshheading:8151316-Receptor, Epidermal Growth Factor
|
pubmed:year |
1994
|
pubmed:articleTitle |
Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.
|
pubmed:affiliation |
Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Clinical Trial, Phase I
|